All lobbying filings

Monument Advocacy

Monument Advocacy filed a Q3 report for Novartis on October 20, 2026, reporting $60,000 in lobbying income.

Lobbying for Novartis · Vaccine and diagnostic manufacturing

As filed: MONUMENT ADVOCACY for NOVARTIS.

All filings by Monument Advocacy · Everything Novartis has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 20, 2026

Income

$60,000

What the client paid this registrant for the period.

Client based in

District of Columbia

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 3

Health Issues

Issues related to domestic healthcare and pricing; Issues related to cell, gene therapies, and radioligand therapies; Issues related to supply chain management, issues related to intellectual property; issues related to tariffs; issues related to ESRD; Most Favored Nation drug pricing policy

Trade (domestic/foreign)

Issues related to ongoing trade negotiations; Issues related to US/China relations; Issues related to international intellectual property; Issues related to global health; issues related to supply chain; and issues related to tariffs, issues related to ESRD.

Taxation/Internal Revenue Code

Issues related to US and international tax provisions; issues related to ESRD

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.